Xiao D, Kang J, Wang Q
Institute of Respiratory Disease, China Medical University, Shenyang 110001.
Zhonghua Jie He He Hu Xi Za Zhi. 1998 Nov;21(11):654-7.
To determine the changes in blood pressure (BP) and its correlated factors in patients with obstructive sleep apnea syndrome(OSAS).
Retaining manometric tube in radial artery and polysomnography(PSG) were done synchronously in 13 patients with OSAS in whom was diagnosed by whole-night PSG. Oxygen therapy was given to two of the patients and NCPAP treatment was given to four of the patients on the following night.
(1) Six of the patients (46 percent) had daytime hypertension (SBP > 18.7 kPa and/or DBP > 12 kPa), the incidence of transient hypertension during apnea in 7 patients who do not have daytime hypertension was 86% (6/7). (2) Lowest oxygen saturation during sleep was significantly correlated with the level of SBP(r = -0.659, P < 0.05) and DBP(r = -0.677, P < 0.01) in awake, the baseline of SBP(r = -0.777, P < 0.01) and DBP (r = -0.590, P < 0.05) in NREM sleep and that of SBP(r = -0.585, P < 0.05) in REM sleep. In REM sleep, the changes in MBP showed significantly correlation with the changes in oxygen saturation during apnea (r = 0.598, P < 0.05). In NREM sleep, the changes in SBP were significantly correlated with apnea length(r = 0.580, P < 0.05). The changes in BP showed no correlation with apnea index in different sleep stages (P > 0.05). (3) Nocturnal elevation in BP disappeared in four patients who received NCPAP treatment, but not in two patients who received oxygen therapy.
The transient hypertension during apnea might be recurrent episodes in patients with OSAS who have normal daytime BP. Nocturnal hypoxemia and apnea length might play a role in nocturnal elevation in BP in patients with OSAS. Hypoxemia was not the major factor in BP elevation after obstructive apneas. Simple oxygen administration could not normalize the elevation in BP during apnea in patients with OSAS and NCPAP might be an appropriate therapy.
确定阻塞性睡眠呼吸暂停综合征(OSAS)患者的血压(BP)变化及其相关因素。
对13例经整夜多导睡眠图(PSG)诊断为OSAS的患者同步进行桡动脉留置测压管和多导睡眠图(PSG)检查。其中2例患者给予吸氧治疗,另外4例患者于次日夜间给予持续气道正压通气(NCPAP)治疗。
(1)6例患者(46%)有日间高血压(收缩压>18.7kPa和/或舒张压>12kPa),7例无日间高血压患者在呼吸暂停期间短暂性高血压的发生率为86%(6/7)。(2)睡眠期间最低血氧饱和度与清醒时收缩压水平(r = -0.659,P < 0.05)和舒张压水平(r = -0.677,P < 0.01)、非快速眼动(NREM)睡眠时收缩压基线(r = -0.777,P < 0.01)和舒张压基线(r = -0.590,P < 0.05)以及快速眼动(REM)睡眠时收缩压基线(r = -0.585,P < 0.05)显著相关。在REM睡眠中,平均血压(MBP)变化与呼吸暂停期间血氧饱和度变化显著相关(r = 0.598,P < 0.05)。在NREM睡眠中,收缩压变化与呼吸暂停时长显著相关(r = 0.580,P < 0.05)。血压变化在不同睡眠阶段与呼吸暂停指数均无相关性(P > 0.05)。(3)接受NCPAP治疗的4例患者夜间血压升高消失,但接受吸氧治疗的2例患者未消失。
呼吸暂停期间的短暂性高血压可能在日间血压正常的OSAS患者中反复出现。夜间低氧血症和呼吸暂停时长可能在OSAS患者夜间血压升高中起作用。低氧血症不是阻塞性呼吸暂停后血压升高的主要因素。单纯吸氧不能使OSAS患者呼吸暂停期间的血压升高恢复正常,NCPAP可能是一种合适的治疗方法。